Eton Pharmaceuticals, Inc. (ETON)
60.43
+0.65
(+1.09%)
USD |
NASDAQ |
Aug 31, 16:00
61.49
+1.06
(+1.75%)
After-Hours: 19:14
Eton Pharmaceuticals Free Cash Flow : -0.268M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.268M |
| March 31, 2026 | 0.431M |
| December 31, 2025 | 10.19M |
| September 30, 2025 | 12.89M |
| June 30, 2025 | 4.104M |
| March 31, 2025 | -2.60M |
| December 31, 2024 | -9.045M |
| September 30, 2024 | -0.536M |
| June 30, 2024 | -2.615M |
| March 31, 2024 | 3.233M |
| December 31, 2023 | 6.04M |
| September 30, 2023 | 9.256M |
| June 30, 2023 | 4.68M |
| March 31, 2023 | -0.723M |
| December 31, 2022 | 2.033M |
| September 30, 2022 | -9.166M |
| June 30, 2022 | -8.415M |
| Date | Value |
|---|---|
| March 31, 2022 | -10.49M |
| December 31, 2021 | -7.98M |
| September 30, 2021 | -6.835M |
| June 30, 2021 | -8.979M |
| March 31, 2021 | -11.46M |
| December 31, 2020 | -22.40M |
| September 30, 2020 | -19.80M |
| June 30, 2020 | -17.95M |
| March 31, 2020 | -19.94M |
| December 31, 2019 | -19.87M |
| September 30, 2019 | -17.07M |
| June 30, 2019 | -16.16M |
| March 31, 2019 | -13.60M |
| December 31, 2018 | -8.381M |
| September 30, 2018 | -7.626M |
| June 30, 2018 | -7.607M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Nektar Therapeutics | -234.03M |
| Pfizer Inc. | 10.99B |
| Elite Pharmaceuticals, Inc. | 17.53M |
| Daré Bioscience, Inc. | -11.76M |
| Liquidia Corp. | 150.69M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 7.255M |
| Cash from Investing (Quarterly) | 0.005M |
| Cash from Financing (Quarterly) | -0.076M |
| Free Cash Flow Per Share (Quarterly) | 0.2214 |
| Free Cash Flow to Equity (Quarterly) | 9.297M |
| Free Cash Flow to Firm (Quarterly) | 9.593M |
| Free Cash Flow Yield | -0.01% |